Difference between revisions of "Part:BBa K4307042"
m |
m |
||
Line 27: | Line 27: | ||
<br> | <br> | ||
− | |||
− | |||
− | |||
− | |||
<div class="center"> | <div class="center"> | ||
<div class="thumb tnone"> | <div class="thumb tnone"> |
Revision as of 16:41, 13 October 2022
pT7-AffiPmrB-PmrA-PmrC-EGFP
In order to enable the engineered bacteria to react to the proteins on the sperm surface, a protein detection system is constructed in engineered bacteria. We call it affipmrABC system. This system is modified from the two-component system PmrB/A in E.coli. AffiPmrB (BBa_K4307025)protein is the receptor of our system. The extracellular iron (III)-binding motif of PmrB receptor(Trp34 to Glu64) is replaced with another protein named affibody to build AffiPmrB. Affibody is a kind of engineered protein that can recognize Fc fragment of antibody(Stahl et al., 2017). Through our design, bacteria can use antibodies as an intermediate to respond to external protein molecules. PmrA (BBa_K4307026) is corresponding response regulator to mediate cellular responses. PmrC (BBa_K4307027) is the promoter regulated by PmrA. EGFP is the reporter gene of this system.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 907
Illegal BamHI site found at 2172 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 2854
Characterization
The following figure demonstrates our successful construction.
Confocal fluorescent microscope assay was done to characterize the bio brick.
First, IPTG was used to induce the expression of affiPmrB receptor and PmrA protein, and then human IgG antibody was added to the experimental group. Then we detect the fluorescence of EGFP under confocal fluorescence microscope. The experiment shows that compared with the culture medium without antibody, more engineering bacteria produce fluorescence in the culture medium with antibody concentration of 100mM.
Conclusion
The EGFP fluorescence intensity of the E.coli which express this part increases after being induced, however the increment is indeed very low, and is rather unstable. Therefore, in order to use the part in diagnose system, we built a new composite part with AffiPmrBAC and amplifier system T7-T3 (BBa_K4307033).
References
[1] Chen, H. D., & Groisman, E. A. (2013). The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. Annu Rev Microbiol, 67, 83-112.
[2] Stahl, S., Graslund, T., Eriksson Karlstrom, A., Frejd, F. Y., Nygren, P. A., & Lofblom, J. (2017). Affibody Molecules in Biotechnological and Medical Applications. Trends Biotechnol, 35(8), 691-712.